Who is sponsoring NCT05902975?

NCT05902975 is sponsored by Al-Azhar University.

What drugs are being tested in NCT05902975?

Interventions in NCT05902975: Fiber reinforced composite resin space maintainer.

What condition does NCT05902975 study?

NCT05902975 studies Dental Caries in Children.

Is NCT05902975 still recruiting?

NCT05902975 is currently status unknown. Last updated 15 June 2023.

Last reviewed 2023-06-15 · How we verify

NCT05902975

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Antimicrobial Fiber Reinforced Composite Resin Space Maintainer Modified With Silver Nano Particles

Status unknown NA Last updated 15 June 2023

What this trial tests

NA trial testing Fiber reinforced composite resin space maintainer in Dental Caries in Children in 24 participants. Status unknown.

Timeline

21 May 2022

Primary endpoint
15 May 2023

15 July 2023

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	24
Start date	21 May 2022
Primary completion	15 May 2023
Estimated completion	15 July 2023
Sites	1 location across Egypt

Drugs / interventions tested

Fiber reinforced composite resin space maintainer

Conditions studied

Dental Caries in Children — all drugs for Dental Caries in Children →

Sponsor

Al-Azhar University

Who can join

Adults 4 to 9, any sex, with Dental Caries in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fiber reinforced composite resin space maintainer

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Current Overview of Metal Nanoparticles' Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles.
Burlec AF, Corciova A, Boev M, Batir-Marin D, et al · · 2023 · cited 93× · PMID 37895881 · DOI 10.3390/ph16101410
Bioresponsive engineered nanoparticles for immunomodulation.
Hegde M, Mishra A, Banerjee R, Bintee B, et al · · 2025 · cited 4× · PMID 41162977 · DOI 10.1186/s12916-025-04305-6

Verify or expand the search:

Other recruiting trials for Dental Caries in Children

Currently open trials in the same condition.

NCT06759311 — Two Different Minimal Invasive Techniques in Caries Removal of Primary Teeth · NA · active not recruiting
NCT06558955 — Technology-enabled Anticipatory Guidance and Peer Support in Empowering Parents to Prevent Early Childhood Caries · NA · recruiting
NCT06286501 — Targeting of Preventive Treatment for Adolescents at Risk of Oral Diseases · NA · recruiting
NCT07009015 — Impact of Oral Health Program on Al-Lith Children's KAP · NA · recruiting
NCT06545279 — The Success Rate and Acceptability of Conventional and Modified Hall Crowns Among Children and Parents · NA · active not recruiting

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05902975 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 15 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05902975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing